Nu Skin Enterprises (NYSE:NUS - Get Free Report) posted its quarterly earnings data on Thursday, August 7th. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.25 by $0.18, Zacks reports. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. The business had revenue of $386.14 million during the quarter, compared to the consensus estimate of $376.68 million. Nu Skin Enterprises updated its FY 2025 guidance to 1.150-1.350 EPS.
Nu Skin Enterprises Stock Performance
NUS traded down $0.10 on Thursday, reaching $11.44. The stock had a trading volume of 614,246 shares, compared to its average volume of 581,432. Nu Skin Enterprises has a 12-month low of $5.32 and a 12-month high of $11.96. The company has a current ratio of 2.01, a quick ratio of 1.38 and a debt-to-equity ratio of 0.27. The business's 50-day moving average price is $8.65 and its two-hundred day moving average price is $7.59. The company has a market cap of $565.20 million, a P/E ratio of 5.69 and a beta of 0.91.
Nu Skin Enterprises Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 10th. Shareholders of record on Friday, August 29th will be issued a $0.06 dividend. The ex-dividend date of this dividend is Friday, August 29th. This represents a $0.24 dividend on an annualized basis and a yield of 2.1%. Nu Skin Enterprises's payout ratio is presently 11.94%.
Wall Street Analyst Weigh In
Separately, Wall Street Zen downgraded shares of Nu Skin Enterprises from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 9th.
Get Our Latest Stock Report on NUS
Insiders Place Their Bets
In other news, insider Steven Keith Hatchett acquired 6,500 shares of the business's stock in a transaction on Wednesday, May 28th. The stock was bought at an average price of $7.54 per share, with a total value of $49,010.00. Following the completion of the acquisition, the insider owned 162,065 shares of the company's stock, valued at approximately $1,221,970.10. This represents a 4.18% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Edwina D. Woodbury sold 4,532 shares of Nu Skin Enterprises stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $8.44, for a total transaction of $38,250.08. Following the completion of the transaction, the director directly owned 42,947 shares of the company's stock, valued at $362,472.68. The trade was a 9.55% decrease in their position. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by insiders.
Institutional Trading of Nu Skin Enterprises
Several institutional investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. grew its position in shares of Nu Skin Enterprises by 7.2% in the first quarter. Goldman Sachs Group Inc. now owns 1,319,885 shares of the company's stock valued at $9,582,000 after purchasing an additional 88,088 shares during the period. JPMorgan Chase & Co. grew its position in shares of Nu Skin Enterprises by 9.3% in the second quarter. JPMorgan Chase & Co. now owns 764,052 shares of the company's stock valued at $6,105,000 after purchasing an additional 65,060 shares during the period. AQR Capital Management LLC grew its position in shares of Nu Skin Enterprises by 64.6% in the first quarter. AQR Capital Management LLC now owns 350,357 shares of the company's stock valued at $2,530,000 after purchasing an additional 137,475 shares during the period. Caption Management LLC acquired a new stake in shares of Nu Skin Enterprises in the second quarter valued at about $778,000. Finally, Rhumbline Advisers grew its position in shares of Nu Skin Enterprises by 3.7% in the second quarter. Rhumbline Advisers now owns 80,119 shares of the company's stock valued at $640,000 after purchasing an additional 2,856 shares during the period. Institutional investors and hedge funds own 82.84% of the company's stock.
Nu Skin Enterprises Company Profile
(
Get Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Featured Articles

Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.